1h Free Analyst Time
The global menstrual drugs market is forecasted to grow by USD 4.59 billion during 2025-2030, accelerating at a CAGR of 8.4% during the forecast period. The report on the global menstrual drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing global awareness and improved diagnosis of menstrual health disorders, substantial pharmaceutical innovation and expansion of treatment portfolio, favorable reimbursement policies and increasing global healthcare expenditure on women health.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global menstrual drugs market is segmented as below:
By Type
- Hormonal treatments
- Pain relief medications
- PMS and PMDD medications
- Menstrual regulation drugs
- Endometriosis treatments
By Route Of Administration
- Oral medications
- Injectables
- Topical applications
By Distribution Channel
- Retail pharmacies
- Hospital pharmacies
- Online pharmacies
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Russia
- Asia
- Rest of World (RoW)
The report on the global menstrual drugs market covers the following areas:
- Global menstrual drugs market sizing
- Global menstrual drugs market forecast
- Global menstrual drugs market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Menstrual Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Menstrual Drugs Market 2020 - 2024 ($ million)
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 The AI impact on global menstrual drugs market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Type
8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Hormonal treatments - Market size and forecast 2025-2030 ($ million)
- Data Table on Hormonal treatments - Market size and forecast 2025-2030 ($ million)
- Chart on Hormonal treatments - Year-over-year growth 2025-2030 (%)
- Data Table on Hormonal treatments - Year-over-year growth 2025-2030 (%)
- Chart on Pain relief medications - Market size and forecast 2025-2030 ($ million)
- Data Table on Pain relief medications - Market size and forecast 2025-2030 ($ million)
- Chart on Pain relief medications - Year-over-year growth 2025-2030 (%)
- Data Table on Pain relief medications - Year-over-year growth 2025-2030 (%)
- Chart on PMS and PMDD medications - Market size and forecast 2025-2030 ($ million)
- Data Table on PMS and PMDD medications - Market size and forecast 2025-2030 ($ million)
- Chart on PMS and PMDD medications - Year-over-year growth 2025-2030 (%)
- Data Table on PMS and PMDD medications - Year-over-year growth 2025-2030 (%)
- Chart on Menstrual regulation drugs - Market size and forecast 2025-2030 ($ million)
- Data Table on Menstrual regulation drugs - Market size and forecast 2025-2030 ($ million)
- Chart on Menstrual regulation drugs - Year-over-year growth 2025-2030 (%)
- Data Table on Menstrual regulation drugs - Year-over-year growth 2025-2030 (%)
- Chart on Endometriosis treatments - Market size and forecast 2025-2030 ($ million)
- Data Table on Endometriosis treatments - Market size and forecast 2025-2030 ($ million)
- Chart on Endometriosis treatments - Year-over-year growth 2025-2030 (%)
- Data Table on Endometriosis treatments - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral medications - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral medications - Market size and forecast 2025-2030 ($ million)
- Chart on Oral medications - Year-over-year growth 2025-2030 (%)
- Data Table on Oral medications - Year-over-year growth 2025-2030 (%)
- Chart on Injectables - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectables - Market size and forecast 2025-2030 ($ million)
- Chart on Injectables - Year-over-year growth 2025-2030 (%)
- Data Table on Injectables - Year-over-year growth 2025-2030 (%)
- Chart on Topical applications - Market size and forecast 2025-2030 ($ million)
- Data Table on Topical applications - Market size and forecast 2025-2030 ($ million)
- Chart on Topical applications - Year-over-year growth 2025-2030 (%)
- Data Table on Topical applications - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by Distribution Channel
10.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Russia - Market size and forecast 2025-2030 ($ million)
- Data Table on Russia - Market size and forecast 2025-2030 ($ million)
- Chart on Russia - Year-over-year growth 2025-2030 (%)
- Data Table on Russia - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Australia - Market size and forecast 2025-2030 ($ million)
- Data Table on Australia - Market size and forecast 2025-2030 ($ million)
- Chart on Australia - Year-over-year growth 2025-2030 (%)
- Data Table on Australia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Increasing global awareness and improved diagnosis of menstrual health disorders
- Substantial pharmaceutical innovation and expansion of treatment portfolio
- Favorable reimbursement policies and increasing global healthcare expenditure on women health
- Persistent socio-cultural stigma and deficiencies in menstrual health education
- Adverse effect profiles of existing therapies and low patient adherence
- Stringent regulatory scrutiny and payer resistance to premium pricing
- Impact of drivers and challenges in 2025 and 2030
- Ascendancy of non-hormonal treatment modalities
- Integration of digital health and pursuit of personalized medicine
- Strategic focus on disease-modifying therapies over symptomatic relief
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Haleon Plc - Overview
- Haleon Plc - Business segments
- Haleon Plc - Key offerings
- Haleon Plc - Segment focus
- SWOT
- Johnson and Johnson Services - Overview
- Johnson and Johnson Services - Business segments
- Johnson and Johnson Services - Key news
- Johnson and Johnson Services - Key offerings
- Johnson and Johnson Services - Segment focus
- SWOT
- Mallinckrodt Plc - Overview
- Mallinckrodt Plc - Business segments
- Mallinckrodt Plc - Key news
- Mallinckrodt Plc - Key offerings
- Mallinckrodt Plc - Segment focus
- SWOT
- Perrigo Co. Plc - Overview
- Perrigo Co. Plc - Business segments
- Perrigo Co. Plc - Key offerings
- Perrigo Co. Plc - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- Reckitt Benckiser Group Plc - Overview
- Reckitt Benckiser Group Plc - Business segments
- Reckitt Benckiser Group Plc - Key news
- Reckitt Benckiser Group Plc - Key offerings
- Reckitt Benckiser Group Plc - Segment focus
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- Sumitomo Chemical Co. Ltd. - Overview
- Sumitomo Chemical Co. Ltd. - Business segments
- Sumitomo Chemical Co. Ltd. - Key offerings
- Sumitomo Chemical Co. Ltd. - Segment focus
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Menstrual Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Hormonal treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hormonal treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hormonal treatments - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hormonal treatments - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Pain relief medications - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Pain relief medications - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Pain relief medications - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Pain relief medications - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on PMS and PMDD medications - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on PMS and PMDD medications - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on PMS and PMDD medications - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on PMS and PMDD medications - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Menstrual regulation drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Menstrual regulation drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Menstrual regulation drugs - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Menstrual regulation drugs - Year-over-year growth 2025-2030 (%)
Exhibit 58: Chart on Endometriosis treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Endometriosis treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Endometriosis treatments - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Endometriosis treatments - Year-over-year growth 2025-2030 (%)
Exhibit 62: Market opportunity by Type ($ million)
Exhibit 63: Data Table on Market opportunity by Type ($ million)
Exhibit 64: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 65: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 66: Chart on Comparison by Route of Administration
Exhibit 67: Data Table on Comparison by Route of Administration
Exhibit 68: Chart on Oral medications - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Oral medications - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Oral medications - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Oral medications - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Injectables - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Injectables - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 76: Chart on Topical applications - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Topical applications - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Topical applications - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Topical applications - Year-over-year growth 2025-2030 (%)
Exhibit 80: Market opportunity by Route of Administration ($ million)
Exhibit 81: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 82: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 83: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 84: Chart on Comparison by Distribution Channel
Exhibit 85: Data Table on Comparison by Distribution Channel
Exhibit 86: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by Distribution Channel ($ million)
Exhibit 99: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Regional Comparison - Asia
Exhibit 162: Data Table on Regional Comparison - Asia
Exhibit 163: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 196: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 197: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: AbbVie Inc. - Overview
Exhibit 231: AbbVie Inc. - Product / Service
Exhibit 232: AbbVie Inc. - Key news
Exhibit 233: AbbVie Inc. - Key offerings
Exhibit 234: SWOT
Exhibit 235: Bayer AG - Overview
Exhibit 236: Bayer AG - Business segments
Exhibit 237: Bayer AG - Key news
Exhibit 238: Bayer AG - Key offerings
Exhibit 239: Bayer AG - Segment focus
Exhibit 240: SWOT
Exhibit 241: Cipla Inc. - Overview
Exhibit 242: Cipla Inc. - Business segments
Exhibit 243: Cipla Inc. - Key news
Exhibit 244: Cipla Inc. - Key offerings
Exhibit 245: Cipla Inc. - Segment focus
Exhibit 246: SWOT
Exhibit 247: Dr Reddys Laboratories Ltd. - Overview
Exhibit 248: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 249: Dr Reddys Laboratories Ltd. - Key news
Exhibit 250: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 251: Dr Reddys Laboratories Ltd. - Segment focus
Exhibit 252: SWOT
Exhibit 253: GlaxoSmithKline Plc - Overview
Exhibit 254: GlaxoSmithKline Plc - Business segments
Exhibit 255: GlaxoSmithKline Plc - Key news
Exhibit 256: GlaxoSmithKline Plc - Key offerings
Exhibit 257: GlaxoSmithKline Plc - Segment focus
Exhibit 258: SWOT
Exhibit 259: Haleon Plc - Overview
Exhibit 260: Haleon Plc - Business segments
Exhibit 261: Haleon Plc - Key offerings
Exhibit 262: Haleon Plc - Segment focus
Exhibit 263: SWOT
Exhibit 264: Johnson and Johnson Services - Overview
Exhibit 265: Johnson and Johnson Services - Business segments
Exhibit 266: Johnson and Johnson Services - Key news
Exhibit 267: Johnson and Johnson Services - Key offerings
Exhibit 268: Johnson and Johnson Services - Segment focus
Exhibit 269: SWOT
Exhibit 270: Mallinckrodt Plc - Overview
Exhibit 271: Mallinckrodt Plc - Business segments
Exhibit 272: Mallinckrodt Plc - Key news
Exhibit 273: Mallinckrodt Plc - Key offerings
Exhibit 274: Mallinckrodt Plc - Segment focus
Exhibit 275: SWOT
Exhibit 276: Perrigo Co. Plc - Overview
Exhibit 277: Perrigo Co. Plc - Business segments
Exhibit 278: Perrigo Co. Plc - Key offerings
Exhibit 279: Perrigo Co. Plc - Segment focus
Exhibit 280: SWOT
Exhibit 281: Pfizer Inc. - Overview
Exhibit 282: Pfizer Inc. - Product / Service
Exhibit 283: Pfizer Inc. - Key news
Exhibit 284: Pfizer Inc. - Key offerings
Exhibit 285: SWOT
Exhibit 286: Reckitt Benckiser Group Plc - Overview
Exhibit 287: Reckitt Benckiser Group Plc - Business segments
Exhibit 288: Reckitt Benckiser Group Plc - Key news
Exhibit 289: Reckitt Benckiser Group Plc - Key offerings
Exhibit 290: Reckitt Benckiser Group Plc - Segment focus
Exhibit 291: SWOT
Exhibit 292: Sanofi SA - Overview
Exhibit 293: Sanofi SA - Business segments
Exhibit 294: Sanofi SA - Key news
Exhibit 295: Sanofi SA - Key offerings
Exhibit 296: Sanofi SA - Segment focus
Exhibit 297: SWOT
Exhibit 298: Sumitomo Chemical Co. Ltd. - Overview
Exhibit 299: Sumitomo Chemical Co. Ltd. - Business segments
Exhibit 300: Sumitomo Chemical Co. Ltd. - Key offerings
Exhibit 301: Sumitomo Chemical Co. Ltd. - Segment focus
Exhibit 302: SWOT
Exhibit 303: Teva Pharmaceutical Ltd. - Overview
Exhibit 304: Teva Pharmaceutical Ltd. - Business segments
Exhibit 305: Teva Pharmaceutical Ltd. - Key news
Exhibit 306: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 307: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 308: SWOT
Exhibit 309: Zydus Lifesciences Ltd. - Overview
Exhibit 310: Zydus Lifesciences Ltd. - Business segments
Exhibit 311: Zydus Lifesciences Ltd. - Key news
Exhibit 312: Zydus Lifesciences Ltd. - Key offerings
Exhibit 313: Zydus Lifesciences Ltd. - Segment focus
Exhibit 314: SWOT
Exhibit 315: Inclusions checklist
Exhibit 316: Exclusions checklist
Exhibit 317: Currency conversion rates for US$
Exhibit 318: Research methodology
Exhibit 319: Information sources
Exhibit 320: Data validation
Exhibit 321: Validation techniques employed for market sizing
Exhibit 322: Data synthesis
Exhibit 323: 360 degree market analysis
Exhibit 324: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Menstrual Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Hormonal treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hormonal treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hormonal treatments - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hormonal treatments - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Pain relief medications - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Pain relief medications - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Pain relief medications - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Pain relief medications - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on PMS and PMDD medications - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on PMS and PMDD medications - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on PMS and PMDD medications - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on PMS and PMDD medications - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Menstrual regulation drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Menstrual regulation drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Menstrual regulation drugs - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Menstrual regulation drugs - Year-over-year growth 2025-2030 (%)
Exhibit 58: Chart on Endometriosis treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Endometriosis treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Endometriosis treatments - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Endometriosis treatments - Year-over-year growth 2025-2030 (%)
Exhibit 62: Market opportunity by Type ($ million)
Exhibit 63: Data Table on Market opportunity by Type ($ million)
Exhibit 64: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 65: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 66: Chart on Comparison by Route of Administration
Exhibit 67: Data Table on Comparison by Route of Administration
Exhibit 68: Chart on Oral medications - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Oral medications - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Oral medications - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Oral medications - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Injectables - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Injectables - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 76: Chart on Topical applications - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Topical applications - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Topical applications - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Topical applications - Year-over-year growth 2025-2030 (%)
Exhibit 80: Market opportunity by Route of Administration ($ million)
Exhibit 81: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 82: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 83: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 84: Chart on Comparison by Distribution Channel
Exhibit 85: Data Table on Comparison by Distribution Channel
Exhibit 86: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by Distribution Channel ($ million)
Exhibit 99: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Regional Comparison - Asia
Exhibit 162: Data Table on Regional Comparison - Asia
Exhibit 163: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 196: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 197: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: AbbVie Inc. - Overview
Exhibit 231: AbbVie Inc. - Product / Service
Exhibit 232: AbbVie Inc. - Key news
Exhibit 233: AbbVie Inc. - Key offerings
Exhibit 234: SWOT
Exhibit 235: Bayer AG - Overview
Exhibit 236: Bayer AG - Business segments
Exhibit 237: Bayer AG - Key news
Exhibit 238: Bayer AG - Key offerings
Exhibit 239: Bayer AG - Segment focus
Exhibit 240: SWOT
Exhibit 241: Cipla Inc. - Overview
Exhibit 242: Cipla Inc. - Business segments
Exhibit 243: Cipla Inc. - Key news
Exhibit 244: Cipla Inc. - Key offerings
Exhibit 245: Cipla Inc. - Segment focus
Exhibit 246: SWOT
Exhibit 247: Dr Reddys Laboratories Ltd. - Overview
Exhibit 248: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 249: Dr Reddys Laboratories Ltd. - Key news
Exhibit 250: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 251: Dr Reddys Laboratories Ltd. - Segment focus
Exhibit 252: SWOT
Exhibit 253: GlaxoSmithKline Plc - Overview
Exhibit 254: GlaxoSmithKline Plc - Business segments
Exhibit 255: GlaxoSmithKline Plc - Key news
Exhibit 256: GlaxoSmithKline Plc - Key offerings
Exhibit 257: GlaxoSmithKline Plc - Segment focus
Exhibit 258: SWOT
Exhibit 259: Haleon Plc - Overview
Exhibit 260: Haleon Plc - Business segments
Exhibit 261: Haleon Plc - Key offerings
Exhibit 262: Haleon Plc - Segment focus
Exhibit 263: SWOT
Exhibit 264: Johnson and Johnson Services - Overview
Exhibit 265: Johnson and Johnson Services - Business segments
Exhibit 266: Johnson and Johnson Services - Key news
Exhibit 267: Johnson and Johnson Services - Key offerings
Exhibit 268: Johnson and Johnson Services - Segment focus
Exhibit 269: SWOT
Exhibit 270: Mallinckrodt Plc - Overview
Exhibit 271: Mallinckrodt Plc - Business segments
Exhibit 272: Mallinckrodt Plc - Key news
Exhibit 273: Mallinckrodt Plc - Key offerings
Exhibit 274: Mallinckrodt Plc - Segment focus
Exhibit 275: SWOT
Exhibit 276: Perrigo Co. Plc - Overview
Exhibit 277: Perrigo Co. Plc - Business segments
Exhibit 278: Perrigo Co. Plc - Key offerings
Exhibit 279: Perrigo Co. Plc - Segment focus
Exhibit 280: SWOT
Exhibit 281: Pfizer Inc. - Overview
Exhibit 282: Pfizer Inc. - Product / Service
Exhibit 283: Pfizer Inc. - Key news
Exhibit 284: Pfizer Inc. - Key offerings
Exhibit 285: SWOT
Exhibit 286: Reckitt Benckiser Group Plc - Overview
Exhibit 287: Reckitt Benckiser Group Plc - Business segments
Exhibit 288: Reckitt Benckiser Group Plc - Key news
Exhibit 289: Reckitt Benckiser Group Plc - Key offerings
Exhibit 290: Reckitt Benckiser Group Plc - Segment focus
Exhibit 291: SWOT
Exhibit 292: Sanofi SA - Overview
Exhibit 293: Sanofi SA - Business segments
Exhibit 294: Sanofi SA - Key news
Exhibit 295: Sanofi SA - Key offerings
Exhibit 296: Sanofi SA - Segment focus
Exhibit 297: SWOT
Exhibit 298: Sumitomo Chemical Co. Ltd. - Overview
Exhibit 299: Sumitomo Chemical Co. Ltd. - Business segments
Exhibit 300: Sumitomo Chemical Co. Ltd. - Key offerings
Exhibit 301: Sumitomo Chemical Co. Ltd. - Segment focus
Exhibit 302: SWOT
Exhibit 303: Teva Pharmaceutical Ltd. - Overview
Exhibit 304: Teva Pharmaceutical Ltd. - Business segments
Exhibit 305: Teva Pharmaceutical Ltd. - Key news
Exhibit 306: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 307: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 308: SWOT
Exhibit 309: Zydus Lifesciences Ltd. - Overview
Exhibit 310: Zydus Lifesciences Ltd. - Business segments
Exhibit 311: Zydus Lifesciences Ltd. - Key news
Exhibit 312: Zydus Lifesciences Ltd. - Key offerings
Exhibit 313: Zydus Lifesciences Ltd. - Segment focus
Exhibit 314: SWOT
Exhibit 315: Inclusions checklist
Exhibit 316: Exclusions checklist
Exhibit 317: Currency conversion rates for US$
Exhibit 318: Research methodology
Exhibit 319: Information sources
Exhibit 320: Data validation
Exhibit 321: Validation techniques employed for market sizing
Exhibit 322: Data synthesis
Exhibit 323: 360 degree market analysis
Exhibit 324: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global menstrual drugs market: AbbVie Inc., Adorefem, Bayer AG, Cipla Inc., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Haleon Plc, Johnson and Johnson Services, Leeford Healthcare Ltd., Mallinckrodt Plc, Maxwellia Ltd., Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi SA, Sumitomo Chemical Co. Ltd., Teva Pharmaceutical Ltd., The Himalaya Drug Co., Walgreens Boots Alliance Inc., Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is ascendancy of non-hormonal treatment modalities."
According to the report, one of the major drivers for this market is the increasing global awareness and improved diagnosis of menstrual health disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Adorefem
- Bayer AG
- Cipla Inc.
- Dr Reddys Laboratories Ltd.
- GlaxoSmithKline Plc
- Haleon Plc
- Johnson and Johnson Services
- Leeford Healthcare Ltd.
- Mallinckrodt Plc
- Maxwellia Ltd.
- Perrigo Co. Plc
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Sanofi SA
- Sumitomo Chemical Co. Ltd.
- Teva Pharmaceutical Ltd.
- The Himalaya Drug Co.
- Walgreens Boots Alliance Inc.
- Zydus Lifesciences Ltd.
